3101 - 3150 of 8808 Results
Title
Year
-
OPENTitle: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s13024-016-0125-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0125-0Citation Count: 38
-
OPENTitle: Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patientsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100042End Page: 100042Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100042Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100042Citation Count: 8
-
OPENTitle: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 215Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003Best OA location URL: http://doi.org/10.1016/j.expneurol.2008.09.003Citation Count: 240
-
OPENTitle: A comprehensive screening of copy number variability in dementia with Lewy bodiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 75Issue #:Start Page: 223.e1End Page: 223.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S019745801830383XCitation Count: 16
-
RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 15
-
OPENTitle: Remote Digital Monitoring for Medical Product DevelopmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 14Issue #: 1Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12851Citation Count: 19
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: https://doi.org/10.1016/j.omtn.2022.02.007Citation Count: 21
-
OPENTitle: ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stressJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 49Start Page: 31198End Page: 31207Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1922342117Best OA location URL: https://www.pnas.org/content/pnas/117/49/31198.full.pdfCitation Count: 89
-
OPENTitle: Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106287End Page: 106287Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106287Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106287Citation Count: 9
-
OPENTitle: Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s disease: an in vivo11C-BU99008 PET studyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 10Start Page: 3116End Page: 3128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz260Best OA location URL: https://academic.oup.com/brain/article-pdf/142/10/3116/30063806/awz260.pdfCitation Count: 85
-
OPENTitle: Unilateral focused ultrasound thalamotomy for tremor-dominant Parkinson’s disease: blinded evaluation and imaging correlationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf303Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf303/64085583/fcaf303.pdfCitation Count: 0
-
OPENTitle: APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodiesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.70795Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70795Citation Count: 0
- Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage2015OPENTitle: Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damageJournal Name: Journal of NeurochemistryPublisher: WileyVol: 135Issue #: 2Start Page: 347End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13242Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13242Citation Count: 63
-
RESTRICTEDTitle: Teaching program for the Unified Dyskinesia Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 9Start Page: 1296End Page: 1298Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22563Citation Count: 11
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages2022OPENTitle: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophagesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00297-9Best OA location URL: https://www.nature.com/articles/s41531-022-00297-9.pdfCitation Count: 33
-
OPENTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Citation Count: 52
- REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers2015OPENTitle: REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriersJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 13Start Page: 1834End Page: 1839Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26413Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4715645Citation Count: 34
-
RESTRICTEDTitle: International Genetic Testing and Counseling Practices for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1527End Page: 1535Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29442Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10461455/pdf/nihms-1897358.pdfCitation Count: 12
-
OPENTitle: Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samplesJournal Name: Journal of Chromatography APublisher: Elsevier BVVol: 1446Issue #:Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.chroma.2016.04.006Best OA location URL: http://doi.org/10.1016/j.chroma.2016.04.006Citation Count: 227
-
RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
-
OPENTitle: Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: A longitudinal studyJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 4Start Page: 1458End Page: 1469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22715Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.22715?download=trueCitation Count: 65
-
OPENTitle: Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.570424Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.570424/pdfCitation Count: 9
-
OPENTitle: Fears and uncertainties of people with Parkinson's diseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251328565Best OA location URL: https://doi.org/10.1177/1877718x251328565Citation Count: 0
-
OPENTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7448947Citation Count: 49
-
OPENTitle: Disease progression models for dominantly-inherited Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1244End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awy089Best OA location URL: https://academic.oup.com/brain/article-pdf/141/5/1244/25083196/awy089.pdfCitation Count: 3
-
OPENTitle: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisitedJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 7Start Page: 2547End Page: 2556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23192Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23192Citation Count: 78
-
OPENTitle: High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 42Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2406009121Best OA location URL: https://doi.org/10.1073/pnas.2406009121Citation Count: 8
-
OPENTitle: Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 642End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28360Citation Count: 78
-
OPENTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 29
- Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease2023OPENTitle: Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 899End Page: 903Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29342Best OA location URL: https://doi.org/10.1002/mds.29342Citation Count: 13
-
OPENTitle: American Football Play and Parkinson Disease Among MenJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 6Issue #: 8Start Page: e2328644End Page: e2328644Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2808207/bruce_2023_oi_230825_1691002545.87841.pdfCitation Count: 17
-
OPENTitle: The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105312End Page: 105312Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105312Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105312Citation Count: 53
-
OPENTitle: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 888End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26469Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26469Citation Count: 0
-
OPENTitle: Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case seriesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 144Issue #:Start Page: 105027End Page: 105027Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105027Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105027Citation Count: 52
-
OPENTitle: Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson’s disease-linked LRRK2 kinaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.87098Best OA location URL: https://doi.org/10.7554/elife.87098Citation Count: 56
-
OPENTitle: Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 7End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.11.008Best OA location URL: http://www.prd-journal.com/article/S1353802020308592/pdfCitation Count: 5
-
OPENTitle: Progression of regional cortical cholinergic denervation in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac320Best OA location URL: https://doi.org/10.1093/braincomms/fcac320Citation Count: 25
-
OPENTitle: K2S2O8-mediated coupling of 6-amino-7-aminomethyl-thiazolino-pyridones with aldehydes to construct amyloid affecting pyrimidine-fused thiazolino-2-pyridonesJournal Name: Organic & Biomolecular ChemistryPublisher: Royal Society of Chemistry (RSC)Vol: 19Issue #: 44Start Page: 9758End Page: 9772Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1ob01580jBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2021/ob/d1ob01580jCitation Count: 1
-
RESTRICTEDTitle: Excessive daytime sleepiness is associated to the development of swallowing impairment in a cohort of early stage drug naïve Parkinson's disease patientsJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 410Issue #:Start Page: 116626End Page: 116626Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.116626Citation Count: 20
-
OPENTitle: Magnetoelectric nanoparticle technology for mitigating motor deficits in Parkinsonian miceJournal Name: Brain StimulationPublisher: Elsevier BVVol: 18Issue #: 5Start Page: 1551End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2025.08.008Best OA location URL: https://doi.org/10.1016/j.brs.2025.08.008Citation Count: 1
-
RESTRICTEDTitle: Diplopia in the Spinocerebellar Ataxias: Prevalence, Risk Factors, and Association with FallsJournal Name: Neuro-OphthalmologyPublisher: Informa UK LimitedVol: 49Issue #: 3Start Page: 255End Page: 260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/01658107.2025.2468446Citation Count: 0
-
OPENTitle: Radioligands Targeting the Purinergic P2X ReceptorsJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 13Start Page: 984End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14130984Best OA location URL: https://www.mdpi.com/2073-4409/14/13/984/pdf?version=1751010309Citation Count: 0
-
OPENTitle: Targeting short-chain fatty acids receptors signalling for neurological disorders treatmentJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol:Issue #:Start Page: 100End Page: 107Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2024.00073Best OA location URL: https://www.explorationpub.com/uploads/Article/A100473/100473.pdfCitation Count: 2
-
RESTRICTEDTitle: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 39Issue #: 3Start Page: 352End Page: 361Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001Best OA location URL: https://doaj.org/article/63e10c65eb3f433c933e3bf217f2f015Citation Count: 150
-
OPENTitle: Distinct AQP4 Alterations in Movement Disorders with Primary SynucleinopathyJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70023Citation Count: 0
-
OPENTitle: Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 96Issue #: 3Start Page: 526End Page: 538Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.27003Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.27003Citation Count: 5
-
OPENTitle: Genome-Wide Association Study of Glucocerebrosidase Activity ModifiersJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 62Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-025-04996-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-025-04996-1.pdfCitation Count: 0
-
RESTRICTEDTitle: Randomized, Controlled Trial of Acupuncture for Fatigue in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1027End Page: 1032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26597Citation Count: 74
-
OPENTitle: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disordersJournal Name: Bioengineering & Translational MedicinePublisher: WileyVol: 9Issue #: 4Start Page: e10665End Page: e10665Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/btm2.10665Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/btm2.10665Citation Count: 2
-
RESTRICTEDTitle: Rasch analysis of anxiety scales in Parkinson's diseaseJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 414End Page: 419Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2013.02.009Citation Count: 30